Security Affairs

MARCH 27, 2020

At least two companies operating in pharmaceutical and manufacturing sectors have been affected. If the latter are the ones to blame, this marks the first time the gang has launched the attacks against pharmaceutical and manufacturing companies and may indicate a significant shift in their modus operandi. .

Healthcare 137

Healthcare Manufacturing Cybersecurity Retail 137

Security Affairs

JUNE 9, 2020

. “The remaining half belong to executives at third-party partners, including European and American companies associated with chemical manufacturing, aviation and transport, medical and pharmaceutical manufacturing, finance, oil and gas, and communications.” Pierluigi Paganini.

Phishing 123

Phishing Healthcare Manufacturing Government 123

Security Affairs

APRIL 7, 2020

According to experts from Group-IB, Russian-speaking threat actors targeted at least two companies in Western Europe in the pharmaceutical and manufacturing industries. Copyright (C) 2014-2015 Media.net Advertising FZ-LLC All Rights Reserved -->. Copyright (C) 2014 Media.net Advertising FZ-LLC All Rights Reserved -->.

Ransomware 124

Ransomware Healthcare Manufacturing Passwords 124

Security Affairs

SEPTEMBER 15, 2020

Department of Justice indictment, MSS-affiliated actors have targeted various industries across the United States and other countries—including high-tech manufacturing; medical device, civil, and industrial engineering; business, educational, and gaming software; solar energy; pharmaceuticals; and defense—in a campaign that lasted over ten years.[

Government 106

Government Energy and Utilities Healthcare Access 106

Hunton Privacy

JULY 17, 2015

On July 10, 2015, the United States House of Representatives passed the 21st Century Cures Act (the “Act”), which is intended to ease restrictions on the use and disclosure of protected health information (“PHI”) for research purposes.

Healthcare 49

Healthcare Privacy Manufacturing Marketing 49

ARMA International

OCTOBER 16, 2019

For example, consider the hypothetical case of Class Action Plaintiffs vs. ABC Pharmaceutical Company. 13, 2014); In re Xarelto (Rivaroxaban) Prods. 2592 Section L (E.D. 20, 2016); St. Janssen-Counotte , 104 F. 3d 1150 (D.

Compliance 56

Compliance e-Discovery GDPR Privacy 56

Security Affairs

MARCH 25, 2020

Victims operate in the Banking/Finance, Construction, Defense Industrial Base, Government, Healthcare, High Technology, Higher Education, Legal, Manufacturing, Media, Non-profit, Oil & Gas, Petrochemical, Pharmaceutical, Real Estate, Telecommunications, Transportation, Travel, and Utility. . concludes the report.

Healthcare 145

Healthcare Education Manufacturing Government 145